Smart Inhalers Market Share, Trends and Growth Analysis By Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), End User (Hospitals & Clinics, Respiratory Care Centers and others) - Forecast till 2030

Smart Inhalers Market Overview

As per the analysis conducted by Market Research Future (MRFR), the Smart Inhalers market is anticipated to acquire the market value of USD 1.35 Billion while thriving at a CAGR of 23.5% by 2030. 

The growing awareness about the advantage of smart inhalers over conventional inhalers, the on-going technological advancements in smart inhalers, and the increasing prevalence of respiratory disorders are some of the major drivers fueling the market growth during the forecast period. However, the high price of smart inhalers, data security concerns related to security devices, and regulating government policies may hinder the smart inhaler devices market.

Impact of COVID-19

The outbreak of COVID-19 is expected to grow the demand for smart inhalers owing to the rising demand for an effective device to keep a check on the oxygen level among the COVID infected population. COVID-19 is likely to have a positive impact on the smart inhaler technology market.

Market Dynamics

Drivers

Rising Prevalence of Respiratory Disorders to Propel the Market

The growing prevalence of respiratory disorders such as; asthma and COPD are anticipated to be one of the most significant factors that can grow the market during the forecast period. Furthermore, the rising adoption of smart inhalers for the direct delivery of drugs to the respiratory tract is anticipated to be another salient cause that can augment the smart inhalers market size in the review timeframe.

Opportunities

Growing Partnerships among Manufacturers and Software Companies to offer Significant Opportunities

The established manufacturers of smart inhalers are focusing on collaborating with digital and software companies to meet the rising demands. The partnership is likely to offer various opportunities for expansion to the partners, thereby benefiting the market in the coming period.

Restraints

High Prices of Smart Inhalers to Inhibit the Market Growth

The expenses associated with smart inhalers are expected to hamper the market growth during the forecast period. Also, the lack of awareness regarding the symptoms of asthma and COP is another salient factor that can hinder the market growth during the assessment timeframe.

Challenges

Concerns Regarding Privacy to Pose a Significant Challenge

The concerns regarding the data are likely to pose a major challenge that can hamper the market growth during the forecast period.

Cumulative Growth Analysis

The market is anticipated to grow significantly during the forecast period owing to the growing incidence of asthma and COPD. However, the expenses associated with smart inhalers are likely to hinder the market growth.

Market Segmentation

The smart inhalers market has been segmented into type, application, and end-user.

 By Type

Based on the type, thesmart inhalers market is segmented into the metered-dose inhaler and dry powder inhaler.

By Application

Based on the type, the smart inhalers market is segmented into COPD, market asthma, and others.

By End-User

Based on the type, the smart inhalers market is segmented into respiratory care centers, hospitals & clinics, and others. Among all, the hospitals and clinics segment is predicted to lead the market during the review timeframe.

Regional Analysis

Americas Expected to Dominate the Market Due to Rising Asthma and COPD Cases

The Americas is projected to lead the smart inhalers market during the projection period owing to the expanding patient pool among adult and kids being diagnosed with the disease like asthma and COPD in the region. The incorporation of the latest and the growing affordability of smart inhalers are predicted to grow the market in the region during the assessment period. Among all, the US is anticipated to make the most salient contribution in developing the regional market in the evaluation timeframe.

Europe to Witness Significant Rise Due to the Presence of Key Players

Europe is projected to acquire the second-largest market share during the forecast period owing to the significant contribution of established players of the region. The rising adoption of smart inhalers by hospitals and patients is projected to be a significant cause that can boost the regional market during the review period. Among all, the UK is expected to make the most significant contribution in developing the regional market during the assessment period.

APAC to be the Fastest-Growing Market Due to Rising Development in Emerging Countries

APAC is predicted to be the fastest-growing market during the analysis timeline. The rapid development of the healthcare infrastructure and the on-going technical development is projected to strengthen the regional market during the review timeframe. Besides, economic expansion and industrialization are projected to be some salient cause that can augment the regional market during the forecast period. In addition, India and China are predicted to make a significant contribution to developing the regional market due to the increasing investments in the regions.

MEA to Witness Sluggish Growth during the Forecast Period

The MEA region is projected to witness sluggish growth during the forecast period owing to the presence of low economies and the lack of awareness. However, the presence of untapped market opportunities are likely to give a significant opportunity to the region. Also, the Middle East countries such as; the UAE, Kuwait, and others can boost the regional market due to their economic instability.

Competitive Landscape

The smart inhalers market is a competitive market owing to the presence of new and as well as established players. The growing adoption of digital technology by renowned players is expected to intensify market expansion in the coming period. Besides, the increasing partnership among players is projected to accelerate the competition in the market further.

List of Key Players Covered in the Report

• AstraZeneca (UK)


• Adherium (New Zealand)


• Cohero Health (US)


• Gecko Health Innovations, Inc (US)


• GlaxoSmithKline (UK)


• Inspiro Medical (Israel)


• Propeller Health (US)

Recent Development

• June 2020- Medical devices specialist QIoT has been awarded 50,000 Euros by the UK’s Innovation Agency, Innovate UK, to develop an inhaler that allows the clinicians remotely whether patients with respiratory health conditions are getting the demanded medication. The technology requires the application of IoT.

• December 2020- AstraZeneca, a renowned UK pharmaceutical company, announced that it had received marketing authorization from the Drug Controller General of India for Benralizumab solution, which has been indicated as add-on maintenance for acute asthma.

Report Overview

The report is a thorough analysis of the smart inhalers market. It throws light on the key segments, regions, and the established key players. The report also contains the impact of COVID-19 on the smart inhalers market.

Segmentation Table

Smart Inhalers Market, By Type

• Dry Powder Inhaler


• Metered-Dose Inhaler

Smart Inhalers Market, By Application

• Market Asthma


• COPD

Smart Inhalers Market, By End-User

• Hospitals & Clinics


• Respiratory Care Centers